1. Cronin L, Guyatt G, Griffith L, et al: Development of a health related quality of life questionnaire for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998, 83: 1976-87.
2. Kidson W: Polycystic ovary syndrome: a new direction in treatment. Med J Aust. 1999, 169: 537-40.
3. Jakubowicz DJ, Seppala M, Jakubowicz S, et al: Insulin reduction with metformin increases luteal phase glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2001, 86: 1126-33.
4. Sills ES, Levy DP, Wittkowski KM, Perloe M: Preliminary experience with metformin treatment of polycystic ovary syndrome: reproductive outcomes among 20 consecutive patients. Fertil Steril. 1999, 72(Suppl 1): S187-8.
5. Sills ES, Perloe M, Palermo GD: Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes. Eur J Obstet Gynecol Reprod Biol. 2000, 91: 135-41. 10.1016/S0301-2115(99)00287-0.